Bo Chi

FDA investigator

Appears on 8 documents from 2013 to 2024, most often at sites in California. Most often cites written procedures; deviations (21 CFR 211.100).

8
Documents on file
5.9
Observations per 483
2013
First seen
2024
Most recent

What they cite most

From 47 observations

Activity by year

2013: 1, 2015: 1, 2016: 1, 2018: 1, 2020: 1, 2023: 1, 2024: 2

Where

California 2 · Germany 2 · China 1 · Maryland 1 · Minnesota 1 · North Carolina 1

Is Bo Chi coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Vetter Pharma Fertigung GmbH & Co. KGApr 24, 2024 · Langenargen, Germany
483 Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)Mar 19, 2024 · Ravensburg, Germany
483 WuXi Biologics Co. Ltd.May 9, 2023 · Wuxi, China
483 Takeda Pharmaceuticals U.S.A., Inc.Mar 18, 2020 · Brooklyn Park, Minnesota
483 Amgen, IncMar 16, 2018 · Thousand Oaks, California
483 Amgen, IncJun 6, 2016 · Thousand Oaks, California
483 FUJIFILM Diosynth Biotechnologies U.S.A., IncMay 1, 2015 · North Carolina

About this profile

What does Bo Chi inspect?

Bo Chi appears on 8 documents on file covering 7 sites, most often in California.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Bo Chi is dated Apr 24, 2024.

FDA Investigator Bo Chi: 483s & Inspections · FDA Intel